UTI Gilt Fund (Debt, Gilt)

18 yrs 1 monthsStarted on:21 Jan 2002
₹ 530.62 Cras on: 17 Jan 2020
Mid Term & Long Horizon
Income Generation

Minimum Investment

  • ₹ 5000.00 for Lumpsum

Investment Objective

To generate credit risk-free return through investments in sovereign securities issued by the Central and/ or a state Government.

Exit Load

Scheme Documents

Similar Funds
Principal GSF Fund
Current NAV 34.37
Return (CAGR) 7.96%
Value Research NA
Nippon India gilt securities fund
Current NAV 27.29
Return (CAGR) 6.25%
Value Research
SBI Magnum Gilt Fund
Current NAV 45.21
Return (CAGR) 8.24%
Value Research
Aditya Birla SL Government Securities Fund
Current NAV 56.94
Return (CAGR) 8.95%
Value Research
IDFC Government Securities Fund
Current NAV 24.54
Return (CAGR) 8.40%
Value Research
ICICI Pru Gilt Fund
Current NAV 69.23
Return (CAGR) 9.93%
Value Research
DSP Government Securities Fund
Current NAV 65.34
Return (CAGR) 9.68%
Value Research
Kotak Gilt Investment Fund
Current NAV 67.68
Return (CAGR) 9.50%
Value Research
Axis Gilt Fund
Current NAV 17.6
Return (CAGR) 7.34%
Value Research
HDFC Gilt Fund
Current NAV 39.72
Return (CAGR) 7.70%
Value Research
Baroda Pioneer Gilt Fund
Current NAV 30.53
Return (CAGR) 6.46%
Value Research
Tata Gilt Securities Fund
Current NAV 56.82
Return (CAGR) 8.90%
Value Research


TenureReturns (CAGR)
1 Month0.79
3 Month0.81
1 YR12.31
2 YR8.98
3 YR6.78

SIP Returns

TenureReturns (CAGR)
1 YR9.22
2 YR10.32
3 YR8.48
5 YR8.63
10 YR9.32


Company Name% Assets
GOI 07/10/2029 6.45%28.05
Reserve Bank of India 76-D 17/03/202018.65
GOI 08/04/2026 7.27%9.72
GOI 04/11/2024 6.18%9.31
Rajasthan State 27/02/2029 8.44%5.1
GOI 22/06/2045 8.13%3.16
GOI 14/01/2029 7.26%2.92

Top Sectoral Holdings

Sector Name% Assets


Standard Deviation3.97%
Sharpe Ratio0.39

Amandeep Singh Chopra

Mr. Chopra is a B.Sc. from St.Stephen's College and an MBA from FMS, Delhi.
He has been with associated with UTI AMC for over two decades.

Other Funds Managed by Amandeep Singh Chopra

  • Nav as on 16 Jan 20 50.21
    Returns since inception (CAGR) 7.73%
    Value Research